Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Cytovance Biologics
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Collaboration to focus on using Akshaya’s proprietary Chimigen® Platform Technology to execute bulk drug products of both COVID-19 and HBV vaccines to be used in Phase I clinical trials by Cytovance.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
April 23, 2020
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Cytovance Biologics
Deal Size : Undisclosed
Deal Type : Collaboration
Reset All
